TradesZ
Top 10 stocks to add now

AVGO vs CRWD — which is the better buy? — what our data shows

⚡ TradesZ research ·Updated July 15, 2026 ·~2 min read ·Grounded in SEC data

AVGO and CRWD are both big names in tech — one makes chips, one protects companies from hackers — but our data is telling pretty different stories about each right now.

Everyone wishes they'd bought Nvidia early. Here's how to spot the next one.

The biggest winners of the last decade had one thing in common. Our data follows those exact moves — and turns them into 10 names to watch right now.

The big names in the AI, Space, Nuclear and Robotics race. The window to get in early is closing fast. Don't wait.

See the top 10 stocks now — free ›

What our data shows

Broadcom Inc. logo AVGO Broadcom Inc. 🟢Bullish lean
Our data shows no red flags at all for Broadcom — it's a clean bill of health based on everything we track.
CrowdStrike Holdings, Inc. Class A Common Stock logo CRWD CrowdStrike Holdings, Inc. Class A Common Stock 🔴Bearish lean
CrowdStrike has had 2 top-executive changes in the last six months, which can be a sign of instability inside the company — that's a caution flag worth watching.
Cybersecurity ⚠ 2 officer-change 8-K filings in last 180 days — leadership instability.

The takeaway

⚪Neutral

AVGO comes in clean with no warning signs, while CRWD has had two leadership shake-ups recently, which is worth keeping an eye on before getting too comfortable with it.

But watch out
Smart-money signals lag the market (13F filings ~45 days) and never guarantee direction — always check the latest price and news yourself.
Sources → Smart-money hub
📈
Before you buy

Before you buy anything —

See the 10 stocks our team is most bullish on right now — under-the-radar names we believe have monster upside potential, in plain English. Free.

Show me the 10 stocks — free →
Free · no credit card · unsubscribe in one click

Have your own question?

Ask in plain English — our data answers. Free for retail readers.

Ask a question →

Informational research, not personalized investment advice.